跳至主要内容
临床试验/NCT03826264
NCT03826264招募中不适用

a Multinational Multicenter Prospective Transpacific TAVR Registry

Duk-Woo Park, MD7 个研究点 分布在 3 个国家目标入组 10,000 人开始时间: 2019年6月15日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
10,000
试验地点
7
主要终点
Event rate of all cause death

研究概览

简要总结

This registry evaluates the long-term outcome of Transcatheter aortic valve replacement (TAVR) in real-world clinical practice.

详细描述

This study is connected with Asian TAVR registry(NCT02308150). Some subjects from Asian TAVR registry continue 10 years follow-up on this TP-TAVR registry.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All patients undergoing TAVR
  • Informed consent

排除标准

  • 未提供

结局指标

主要结局

Event rate of all cause death

时间窗: 1 year

次要结局

  • Event rate of Permanent pacemaker insertion(10 years)
  • NYHA class(1 year)
  • Event rate of free from atrial fibrillation(10 years)
  • Event rate of bleeding(10 years)
  • Event rate of cerebrovascular accident(10 years)
  • Event rate of Vascular access site and access-related complication(30 days)
  • Event rate of Prosthetic valve dysfunction(10 years)
  • Event rate of Composite endpoint(10 years)
  • Event rate of Structural valve deterioration(10 years)
  • Event rate of cardiovascular death(10 years)
  • Event rate of myocardial infarction(10 years)
  • Event rate of Acute kidney injury(30 days)
  • Event rate of Other TAVR-related complication(10 years)
  • Valve area(1 year)

研究者

发起方
Duk-Woo Park, MD
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Duk-Woo Park, MD

Professor, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

Asan Medical Center

研究点 (7)

Loading locations...

相似试验